Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 239 blog entries.

MHRA Class 2 Medicines Recall: Loperamide Hydrochloride Capsules 2mg (Strides Pharma UK Limited)

Drug alert number: EL (24)A/36 Date issued: 15 July 2024 Strides Pharma UK Ltd is recalling the listed batch as a precautionary measure due to an out of specification result for microbial contamination, reported during retesting: Loperamide Hydrochloride Capsules 2mg (Strides Pharma UK Limited) PL 13606/0045 SNOMED Code: 18283311000001106 Batch No Expiry Date Pack Size [...]

The post MHRA Class 2 Medicines Recall: Loperamide Hydrochloride Capsules 2mg (Strides Pharma UK Limited) appeared first on Community Pharmacy England.

By |August 15th, 2024|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Loperamide Hydrochloride Capsules 2mg (Strides Pharma UK Limited)

MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)

Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Drug alert number: EL (24)A/36 Date issued: 12 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) Company name: Star Pharmaceuticals Limited Product name: Diflucan Oral [...]

The post MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |August 12th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Diflucan Oral Suspension 40mg/ml (Star Pharmaceuticals Limited)

Rivaroxaban tablets – changes to reimbursement from September 2024

Currently all branded and generically written prescriptions for Rivaroxaban tablets are reimbursed in line with NHS list prices of the brand originator Xarelto®. However, licensed generic Rivaroxaban tablets have been available in the market for several months following the patent expiry of Xarelto®. Consequently, selling prices of generic Rivaroxaban tablets have fallen sharply when compared [...]

The post Rivaroxaban tablets – changes to reimbursement from September 2024 appeared first on Community Pharmacy England.

By |August 9th, 2024|Lexpos News|Comments Off on Rivaroxaban tablets – changes to reimbursement from September 2024

MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)

Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Drug alert number: EL (24)A/35 MDR number: MDR 113-05/24 Date issued: 08 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) Company name: Accord-UK Ltd Product name: Trandolapril 0.5mg [...]

The post MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd) appeared first on Community Pharmacy England.

By |August 8th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Trandolapril 0.5mg, 2mg, 4mg Capsules (Accord-UK Ltd)

Medicine Supply Notification: Cefalexin 500mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 500mg tablets. MSN/2024/083 Tier 2 – medium impact Date of issue: 6th August 2024 Cefalexin 500mg tablets are out of stock until mid-September 2024. Cefalexin 500mg capsules remain available and can support an uplift in demand. Alternative cefalexin preparations remain [...]

The post Medicine Supply Notification: Cefalexin 500mg tablets appeared first on Community Pharmacy England.

By |August 7th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Cefalexin 500mg tablets